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Membrane rafts are domains enriched in sphingolipids, glycolipids and cholesterol that are able to com-
partmentalize cellular processes. Noteworthy, many proteins have been assigned to membrane rafts
including those related to the control of the synaptic vesicle release machinery, which is a important step
for neurotransmission between synapses. In this work, we have investigated the role of cholesterol in key
steps of glutamate release in isolated nerve terminals (synaptosomes) from rat brain cortices. Incubation
of synaptosomes with methyl-b-cyclodextrin (MbCD) induced glutamate release in a dose-dependent
fashion. HcCD, a cyclodextrin with low afﬁnity for cholesterol, had no signiﬁcant effect on spontaneous
glutamate release. When we evaluated the effects of MbCD on glutamate release induced by depolarizing
stimuli, we observed that MbCD treatment inhibited the KCl-evoked glutamate release. The glutamate
release induced by MbCD was not altered by treatment with EGTA nor with EGTA-AM. The KCl-evoked
glutamate release was no further inhibited when synaptosomes were incubated with MbCD in the
absence of calcium. We therefore investigated whether the cholesterol removal by MbCD changes intra-
synaptosomal sodium and calcium levels. Our results suggested that the cholesterol removal effect on
spontaneous and evoked glutamate release might be upstream to sodium and calcium entry through
voltage-activated channels. We therefore tested if MbCD would have a direct effect on synaptic vesicle
exocytosis and we showed that cholesterol removal by MbCD induced spontaneous exocytosis and inhib-
ited synaptic vesicle exocytosis evoked by depolarizing stimuli. Lastly, we investigated the effect of pro-
tein kinase inhibitors on the spontaneous exocytosis evoked by MbCD and we observed a statistically
signiﬁcant reduction of synaptic vesicles exocytosis. In conclusion, our work shows that cholesterol
removal facilitates protein kinase activation that favors spontaneous synaptic vesicles and consequently
glutamate release in isolated nerve terminals.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Lipid rafts are cholesterol and sphingolipid enriched membrane
microdomains that segregate proteins on plasma membrane (Si-
mons and Ikonen, 1997). These microdomains were renamed to
membrane rafts since they are associated to signaling proteins
such as ion channels, membrane receptors and transporters (Pike,
2006). During the last decade, many studies performed in nerve
cells revealed that membrane raft plays an important role in neu-
rotransmission by regulating synapse function in the central and
peripheral nervous system. Indeed, in a pioneering work, Zamirde Morfologia, Instituto de
rais, Av. Antônio Carlos 6627,
31 34092824; fax: +55 31
).
sevier OA license.and Charlton (2006) revealed that cholesterol depletion by
methyl-b-cyclodextrin (MbCD) blocked the action potential-
evoked transmission at crayﬁsh neuromuscular junction. These
authors also observed that MbCD treatment increased the sponta-
neous transmitter release, which involves some, but not all the
steps in Ca+2 triggered exocytosis. Using another preparation, Was-
ser et al. (2007) described that cholesterol depletion of synaptic
vesicle with MbCD impaired evoked neurotransmission and aug-
mented spontaneous fusion rate at hippocampal neurons.
In summary, there are studies that investigated the role of cho-
lesterol in presynaptic mechanisms that govern neurotransmission
using diverse models such as the neuromuscular junction (Zamir
and Charlton, 2006; Petrov et al., 2010), neurons in culture (Wasser
et al., 2007; Frank et al., 2008; Linetti et al., 2010; Smith et al.,
2010) and rat brain synaptosomes (Gil et al., 2005; Borisova
et al., 2009, 2010; Tarasenko et al., 2010). However, to our knowl-
edge, none of them have investigated how acute cholesterol re-
moval by MbCD affects spontaneous and evoked glutamate
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aptic vesicle exocytosis in isolated nerve terminal in the same
experimental condition. To address this question, we therefore
used rat brain synaptosomes and ﬂuorimetric assays to investigate
the effects of the cholesterol removal agent MbCD on key steps that
regulate glutamate release.
Glutamate is the major excitatory neurotransmitter in the
mammalian central nervous system and plays a dominant role in
fast neurotransmission in the mammalian brain. Due to patholog-
ical release of glutamate during brain ischemia and neurodegener-
ative disorders, many studies have been conducted with the aim to
understand the presynaptic mechanisms governing the release of
this neurotransmitter. In this work, we have provided new evi-
dences supporting the role of cholesterol as an essential compo-
nent that control glutamate release machinery, more speciﬁcally,
by restraining spontaneous vesicular release.2. Material and methods
2.1. Chemicals
Glutamate dehydrogenase type II (GDH), NADP+, glutamate,
fura-2,sucrose, Percoll, sodium dodecyl sulfate (SDS), Ethylene gly-
col bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid (EGTA),
Hepes, methyl-b-cyclodextrin (MbCD), KN93, Calphostin C and
hidroxi-propil-c-cyclodextrin (HcCD) were obtained from Sigma
Aldrich (Labsciences). FM2-10, SBFI-AM and acetoxymethyl ester
(Fura2-AM) were purchased from Invitrogen TM. PKI was purchased
from Santa Cruz Biotechnology. The Kit LDH Liquiform was ob-
tained from Labtest Diagnóstica S. A. All other reagents were of
analytical grade obtained from commercial sources.
2.2. Puriﬁcation of synaptosome
In our experiments, synaptosomal preparations were obtained
from adult Wistar rats of both sexes (180–200 g) which were
decapitated and had their cortices removed and homogenized
1:10 (w/v) in 0.32 M sucrose solution containing dithiothreitol
(0.25 mM) and EDTA (2 mM). Then, homogenates were submitted
to low-speed centrifugation (1000g for 10 min) and synaptosomes
were puriﬁed from the supernatant by discontinuous Percoll-den-
sity gradient centrifugation (Dunkley et al., 1988) with small mod-
iﬁcations (Romano-Silva et al., 1993). The isolated nerve terminals
were ressuspended in Krebs–Ringer-Hepes solution (KRH; 124 mM
NaCl, 4 mM KCl, 1.2 mMMgSO4, 10 mM glucose, 25 mMHepes, pH
7.4) with no CaCl2 to a concentration of 10 mg/ml, divided into ali-
quots of 200 ll and kept in ice until loaded with fura-2AM, SBFI or
used for glutamate release or exocytosis assays. All experimental
procedures were approved by the local ethics committee (CETEA)
and performed according to their guidelines. In addition, all efforts
were made to minimize animal suffering and to reduce the number
of animals per experiment.
2.3. Measurement of continuous glutamate release
Glutamate release was accessed by continuous ﬂuorimetric as-
say described by Nicholls et al. (1987). Brieﬂy, synaptosomes
(10 mg/ml) were incubated for 60 min, washed with KRH medium,
and transferred to a cuvette (ﬁnal synaptosomal concentration of
0.5 mg/ml to 1 mg/ml) at 37 C with constant stirring. At the begin-
ning of each assay, CaCl2 (1 mM), NADP+ (1 mM) and glutamate
dehydrogenase (50 units) were added to synaptosomes. By
following the increase in ﬂuorescence due to the production of
NADPH in the presence of glutamate dehydrogenase and NADP+,
we could continuously measure the amount of glutamate released.Fluorescence emission was recorded using a ﬂuorimeter (Shimadzu
RF-5301PC) at 450 nm and the excitation wavelength was set at
360 nm. CaCl2 was omitted from experiments performed in the
presence of 1.0 mM EGTA for the purpose to assess the calcium-
independent glutamate release. Synaptosomes were previously
incubated with MbCD (0.05–10 mM) during different time periods
(5–30 min) (not shown). We chose the time period of 10 min for
all the experiments described in this article. In experiments with
HcCD, the synaptosomal suspensions were incubated with the drug
for 10 min at concentrations of 1 and 10 mM. Glutamate release
was evoked by depolarizing stimuli KCl 33 mM.
2.4. Measurements of intrasynaptosomal free Ca2+ concentrations
Intrasynaptosomal free Ca2+ concentrations were measured by
the ﬂuorescent calcium dye Fura-2 AM using a protocol described
by Prado et al. (1996). Synaptosomal suspensions (10 mg ml1)
were incubated for 50 min (37 C) with fura-2 AM (stock solution
1 mM in DMSO), to a ﬁnal concentration of 5 lM and then diluted
with KRH. After a further 10 min incubation period, Fura-2 labeled
synaptosomes were washed, ressuspended in medium (1 mg ml1)
and immediately used for ratiometric quantiﬁcation of intracellu-
lar free calcium ([Ca2+]i) in the spectroﬂuorimeter. Fluorescence
emission was recorded at 500 nm at an excitation ratio of 330/
380. Calibration of Fura-2 signals and estimation of synaptosomal
auto ﬂuorescence were performed as described by Prado et al.
(1996). Calcium (2 mM, ﬁnal concentration) was added to the syn-
aptosomal suspension 30 s after starting each assay. Calcium inﬂux
was evoked by depolarizing stimuli KCl 33 mM. Isolated nerve ter-
minals were stirred throughout the experiment in a cuvette main-
tained at 37 C. Synaptosomes were previously incubated with
MbCD (1 and 10 mM) for 10 min.
2.5. Measurements of intrasynaptosomal sodium levels
Intracellular sodium measurements were performed according
to Massensini et al. (1998). Synaptomes were loaded with SBFI in
a similar fashion as described for Fura-2, except that 10 mM
SBFI-AM was mixed to Pluronic (1% ﬁnal concentration) at 1:1
(v:v) before adding to the synaptosomal suspension. The medium
was modiﬁed by replacing NaCl with choline chloride and the pH
was set to 7.4 by addition of TRIZMA-base (1 M stock). After load-
ing synaptosomes with the dye, the suspension was centrifuged
and the pellets were ressuspended in 2.0 ml of KRH and transferred
to the cuvette. At the end of each assay, gramicidin D was added to
a ﬁnal concentration of 2 mM to allow equilibration of [Na+]I with
[Na +]o. Synaptosomes were previously incubated with MbCD (1
and 10 mM) for 10 min in aliquots tests.
2.6. Measurements of synaptic vesicle exocytosis with FM2-10
Measurements of synaptic vesicles exocytosis was performed
using FM2-10, a ﬂuorescent styryl dye from the FM family intro-
duced by Betz et al. (1996). Synaptosomal suspension (500 ll)
was diluted to 1.0 ml with KRH medium in a stirred cuvette and
incubated with FM2-10 (50 lM) and 1.3 mM calcium for 3 min at
37 C according to De Castro et al. (2008). Synaptosomes were
stimulated with KCl 33 mM, washed with two short 10 s spins to
remove externally bound dye, and ressuspended in 2 ml of fresh
KRH. Labeled vesicles were released during a second round of ves-
icle cycling, stimulated with KCl (33 mM) in KRH medium. We
measured the decrease in ﬂuorescence [(FF0)/F0] in synapto-
somes that were excited at 488 nm and collecting at 570 nm. The
aliquots were pre-incubated with MbCD (1 and 10 mM) or HPcCD
(1 and 10 mM) before the second round of vesicle cycling and data
collection in ﬂuoremeter.
Fig. 1. MbCD increases glutamate release in a reversible, dose-dependent fashion. Synaptosomes were incubated with increasing concentrations of MbCD and the continuous
release of glutamate was measured. (A) Representative traces of continuous glutamate release curves after treatment with KCl 33 mM, MbCD 1, or 10 mM. (B) Quantitative
analysis of glutamate release induced by MbCD 0.05, 0.1, 0.5, 1, 2.5, 5 and 10 mM (⁄p < 0.05 compared to control). (C) Incubation with HcCD (1 and 10 mM) does not alter
glutamate release (⁄⁄p < 0.05 compared to KCl). (D) MbCD effect on glutamate release is reverted by cholesterol replenishment (⁄p < 0.05 compared to control). When
synaptosomes were incubated with Ch-MbCD (1 mM), after cholesterol depletion by MbCD (1 mM), glutamate release was similar to that obtained in control conditions. (E)
Synaptosomes were incubated with MbCD (1 and 10 mM) or HcCD (1 and 10 mM) for 10 min and the release of lactate dehydrogenase (LDH) was measured. The
synaptosomal membrane rupture was obtained by incubating with Triton X-100 0.1%. The control represents the release of LDH in the absence of cyclodextrins and the Triton
X-100 (⁄⁄⁄p < 0.05 compared to Triton X-100). The results represent mean ± S.E.M of at least three independent experiments.
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solution at the same time so we established a new staining proto-
col for the experiments described in Fig. 6 based on the one de-
scribed by Smith et al. (2010). Synaptosomal suspension (500 ll)
was diluted to 1.0 ml with KRH medium in a stirred cuvette and
incubated with MbCD (1/10 mM) for 10 min at 37 C. The suspen-
sion was washed for 30 s and ressuspended to 1 ml with KRH med-
ium and then incubated with FM2-10 (50 lM) and 1.3 mM calcium
for additional 10 min at 37 C. The synaptosomes were then
washed 3 times for 30 s with KRHMedium plus albumin to remove
externally bound dye, and ressuspended in 2 ml of fresh KRH. La-
beled vesicles were released during a second round of vesicle cy-
cling, stimulated with MbCD (1 mM or 10 mM) in KRH medium.
The kinase inhibitors were added just before the second round ofvesicle cycling and data collection was performed essentially as de-
scribed above.
2.7. Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) release was monitored in order to
evaluate the integrity of synaptosomal preparations after incuba-
tion with MbCD (1 and 10 mM) and HcCD (1 and 10 mM) during
10 min. The LDH activity in the incubation medium and the total
LDH activity, which was determined by synaptosomal preparations
disruption using 0.1% Triton X-100, were assayed using the LDH
Liquiform kit (Labtest Diagnóstica S. A. Brazil). LDH activity was
determined by spectrophotometric measurement at 340 nm of
NADH (360 lM) oxidation in the presence of excess pyruvate
Fig. 2. MbCD inhibits glutamate release evoked by KCl depolarization. Synaptosomes were depolarized with 33 mM KCl and the continuous release of glutamate was
followed. (A) Representative traces of continuous glutamate release curves after treatment with MbCD 0.05, 1 and 10 mM in the presence of KCl 33 mM. (B) Quantitative
analysis of KCl-evoked glutamate release when synaptosomes were incubated with MbCD 0.05, 0.5, 1, 5 and 10 mM (⁄p < 0.05 compared to KCl). (C) Incubation with HcCD 1
and 10 mM does not interfere with KCl-evoked glutamate release. (D) MbCD effect on evoked glutamate release can be reverted by cholesterol replenishment. Incubation
with MbCD (1 mM) decreases the evoked glutamate release (⁄p < 0.05 compared to KCl). When membrane cholesterol was replaced by Ch-MbCD (1 mM) after cholesterol
depletion by MbCD (1 mM), glutamate release was reestablished to levels similar to that obtained by KCl alone (⁄⁄p < 0.05 compared to MbCD + KCl). The results represent
mean ± S.E.M of at least three independent experiments.
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the absence of cyclodextrins or Triton X-100.2.8. Statistical analysis
Results shown in this work represent the mean of at least three
independent experiments. Statistical signiﬁcance was accessed by
analysis of variance (ANOVA). A value of p < 0.05 was considered
to be statistically signiﬁcant.3. Results
It is well established that proteins involved in vesicular neuro-
transmitter release, such as SNARE proteins and voltage-gated cal-
cium channels, are found in membrane rafts (Gil et al., 2005;
Taverna et al., 2004). These data prompted us to investigate the ef-
fect of MbCD on continuous glutamate release from rat brain syn-
aptosomes. Initially, we tested if different concentrations of MbCD,
a cholesterol scavenger agent that remove cholesterol from the
plasma membrane, interfere with spontaneous glutamate release
measured by a ﬂuorimetric assay (see Section 2). When synapto-
somes were incubated with increasing concentrations of MbCD
(1, 2.5, 5 and 10 mM), we observed an increase in glutamate re-
lease (Fig. 1A and B). We next performed two control experiments
to test if the glutamate release induced by MbCD was due to cho-
lesterol removal from the plasma membrane. First, synaptosomes
were incubated with HcCD, a cyclodextrin with low afﬁnity for
cholesterol and Fig. 1C shows that HcCD (1 and 10 mM) had no sig-niﬁcant effect (p > 0.05) on spontaneous glutamate release. We
next treated the cholesterol depleted synaptosomal preparation
with cholesterol conjugated with MbCD (Ch-MbCD-1 mM).
Fig. 1D shows that cholesterol removal with MbCD (1 mM) was
reversible. We also evaluated the integrity of synaptosomal prepa-
rations after incubation with MßCD (1 and 10 mM) and HcCD (1
and 10 mM) during 10 min. The graph in Fig. 1E shows that the
spontaneous glutamate release induced by removal of cholesterol
occurred not by a non-speciﬁc leakage, since the release of LDH in-
duced by MbCD was very low and not statistically different from
control.
We next investigated the effects of MbCD on glutamate release
induced by depolarizing stimuli. Synaptosomes were treated with
MbCD (1, 5 and 10 mM) and then depolarized with KCl (33 mM).
Fig. 2A and B show that MbCD (1, 5 and 10 mM) inhibited the
KCl-evoked glutamate release. By contrast, incubation with HcCD
1 and 10 mM, had no signiﬁcant effect on glutamate release evoked
by depolarizing stimulus (Fig. 2C). The MbCD effect on evoked glu-
tamate release could be reverted by cholesterol replenishment
(Fig. 2D).
Thiele et al. (2000) have pointed out that MbCD (3.8 mM)
caused a 60–70% cholesterol depletion in PC12 cells and that high-
er concentrations resulted in changes in cell morphology that
could account for unspeciﬁc effects of the drug. Therefore, to min-
imize secondary effects, for the next set of experiments, we chose
two doses of MbCD (1 and 10 mM) and compared the effects of
both.
Since voltage-gated calcium channels are concentrated in mem-
brane rafts (Taverna et al., 2004), we next investigated if the MbCD
Fig. 3. MbCD effects on glutamate release in the absence of calcium. (A) Representative traces of continuous glutamate release curves after treatment with MbCD 1 mM in the
presence of EGTA (2 mM) or EGTA-AM (50 lM). (B) EGTA (2 mM) or EGTA-AM (50 lM) did not change glutamate release induced by MbCD 1 mM (⁄p < 0.05 compared to
control; ⁄⁄p < 0.05 compared to KCl). (C) Representative traces of continuous glutamate release curves after treatment with MbCD 1 mM in the presence of EGTA (2 mM) and
KCl (33 mM). (D) EGTA inhibited KCl-evoked glutamate release and treatment with MbCD (1 mM) did not induce any further inhibition (⁄⁄p < 0.05 compared to KCl). The
results represent mean ± S.E.M of at least three independent experiments.
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dependent. Synaptosomes were incubated with EGTA (2 mM) or
EGTA-AM (50 lM), an extracellular and intracellular calcium che-
lator respectively. The glutamate release induced by MbCD
(1 mM) was not changed by treatment with EGTA nor with
EGTA-AM (Fig. 3A and B).
We next asked if MbCD inhibition of KCl-evoked glutamate re-
lease was calcium-dependent. Fig. 3C and D shows that EGTA and
MbCD inhibited in approximately 42% and 35% respectively the
calcium dependent component of KCl-evoked glutamate release.
Interestingly, the KCl-evoked glutamate release was no further
inhibited when synaptosomes were incubated with MbCD
(1 mM) and EGTA (Fig. 3D). These ﬁndings suggested that choles-
terol removal by MbCD interferes with the exocytotic (calcium-
dependent) component of KCl-evoked glutamate release without
interfering with the transporter-mediated (calcium-independent)
component.
We measured intrasynaptosomal calcium concentration using
the ﬂuorescent probe Fura 2-AM. Fig. 4A shows representative
traces of changes in intracellular calcium concentration. Synapto-
somes labeled with Fura 2-AM were exposed to MbCD (1 or
10 mM) and these treatments did not induce signiﬁcant changes
in basal or KCl-evoked increase in intrasynaptosomal calcium con-
centration (Fig. 4A and B). These data suggest that the MbCD ac-
tions on spontaneous or evoked glutamate release might not be
due to an effect on voltage-gated calcium channels.
Since sodium inﬂux through voltage-activated sodium channels
is an essential step to neurotransmission, we investigated whether
cholesterol removal by MbCD induced changes in intrasynaptoso-
mal sodium levels Fig. 4C shows that treatment with MbCD (1/
10 mM) did not induce signiﬁcant changes in basal sodium levels.
Veratridine, an alkaloid that activates sodium channels, triggeredan increase in intrasynaptosomal sodium levels compared to basal
(Fig. 4C). The sodium levels increase evoked by veratridine did not
change during treatment with MbCD (1 or 10 mM) (Fig. 4C and D).
These results suggest that the inhibitory effect of cholesterol re-
moval on glutamate release evoked by KCl might be upstream to
sodium and calcium entry through voltage-activated channels.
We next investigated if MbCD would have a direct effect on syn-
aptic vesicle exocytosis that would bypass sodium and calcium in-
ﬂux through voltage-gated channels. Rat brain synaptosomes were
stained with the ﬂuorescent dye FM2-10 and then incubated with
MbCD (see material and methods). Fig. 5A shows representative
FM2-10 destaining curves. The control curve reﬂects exocytosis
of synaptic vesicles that are fusing spontaneously and we observed
that cholesterol removal by MbCD (1 mM) induced spontaneous
synaptic vesicles exocytosis that was not statistically different
from control (Fig. 5A and B). By contrast, exocytosis evoked by
KCl (33 mM) alone was inhibited in approximately 26% inhibited
when synaptosomes were pre-treated with MbCD (1 mM)
(Fig. 5B). Taken together, these data suggested that cholesterol re-
moval by MbCD (1 mM) inhibits synaptic vesicle exocytosis evoked
by depolarizing stimuli and that the effect of MbCD on glutamate
release might be due, at least in part, to an inhibition on exocytosis
of glutamatergic vesicles.
Lastly, we performed experiments as an attempt to identify the
mechanism by which MbCD increases spontaneous exocytosis. We
ﬁrst established a new FM2-10 staining protocol to measure exocy-
tosis of synaptic vesicles that were labeled spontaneously after
cholesterol removal. Fig. 6 A shows the destaining curves for syn-
aptosomal preparations that were stained with FM2-10 following
an incubation period in the presence of MbCD. The ﬂuorescence
decay evoked by MbCD was more pronounced when synaptic ves-
icles were labeled with FM2-10 spontaneously (after cholesterol
Fig. 4. Intrasynaptosomal sodium and calcium levels in the presence of MbCD. Synaptosomes were incubated with Fura 2-AM, followed by treatment with MbCD (1 and
10 mM). (A) Representative intracellular calcium concentration curves in the presence of MbCD (1 and 10 mM) alone or with depolarizing stimuli (KCl 33 mM). (B)
Quantitative analysis of intrasynaptosomal calcium concentration for the conditions indicated (⁄p < 0.05 compared to KCl). The results represent mean ± S.E.M of at least three
independent experiments. (C) Synaptosomes were incubated with the sodium indicator SBFI (10 lM). MbCD 1 and 10 mM were added to synaptosomal suspension and
intrasynatopsomal sodium variation was obtained in the presence and absence of Veratridine 10 lM. Representative curves of increase in SBFI ﬂuorescence in the presence of
MbCD (1 and 10 mM). (D) Quantitative analysis of intrasynaptosomal sodium levels for the conditions indicated (⁄p < 0.05 compared to Vr). The results represent
mean ± S.E.M of at least three independent experiments.
Fig. 5. MbCD effects on synaptic vesicles exocytosis. Synaptosomes were labeled with FM2-10 (see Methods) and then incubated with MbCD for 10 min. The release of FM2-
10 was monitored in the presence and absence of KCl (33 mM). (A) Representative FM2-10 destaining curves for control, MbCD (1 and 10 mM), KCl 33 mM, MbCD 1 mM + KCl
33 mM and MbCD 10 mM + KCl 33 mM). (B) Quantitative analysis of synaptic vesicle exocytosis for the conditions indicated. DF/F0, normalized ﬂuorescence (⁄p < 0.05
compared to KCl). The results represent mean ± S.E.M of at least three independent experiments.
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protein kinases are key signaling proteins that modulated synaptic
response, we used several selective protein kinase inhibitors, to
determine whether kinases regulating neurotransmitter release
were activated by cholesterol depletion. To determine the identity
of kinases mediating the increase in spontaneous exocytosis weassessed the ability of selective PKC, PKA and calcium/calmodulin
kinase II (CaMKII) inhibitors to block the spontaneous exocytosis
induced by cholesterol removal by MbCD. Pretreatment with the
PKC inhibitor Calphostin C (1 lM) for 10 min prevented the spon-
taneous exocytosis induced by MbCD treatment (1 or 10 mM,
Fig. 6A). Calphostin C by itself did not cause a signiﬁcant increase
Fig. 6. Protein kinase inhibition affects the spontaneous exocytosis evoked by MbCD. Synaptosomes were incubated with MbCD for 10 min and then labeled with FM2-10
(see Section 2). (A) Representative FM2-10 destaining curves for control, MbCD (1 and 10 mM). (B–D) Representative FM2-10 destaining curves for control, MbCD (10 mM),
Calphostin C (1 lM), PKI (100 nM) or KN93 (1 lM). (E) Quantitative analysis of synaptic vesicle exocytosis evoked by control, MbCD (1/10 mM) alone or in the presence of
kinase inhibitors as indicated. DF/F0, normalized ﬂuorescence (⁄p < 0.05 compared to MBCD 1 mM and ⁄⁄p < 0.05 compared to MBCD 10 mM). The results represent
mean ± S.E.M of at least ﬁve independent experiments.
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itor PKI (100 nM) or with the CAMKII selective inhibitor KN93
(1 lM) signiﬁcantly reduced the extent of the increase in exocyto-
sis observed following cholesterol extraction when compared with
control experiments performed in parallel (Fig. 6E). The kinase
inhibitors PKI and KN93 did not cause a signiﬁcant increase in
spontaneous exocytosis by their selves (Fig. 6C and D).
Our results therefore demonstrate that spontaneous exocytosis
induced by MbCD is dependent on protein kinase activation and
we suggest that the effects of cholesterol depletion on synaptic
transmission can be partly explained by increased presynaptic ki-
nase activity.4. Discussion
In the present study, we aimed to investigate, using the same
experimental conditions, the effect of cholesterol removal on con-
tinuous glutamate release, intracellular sodium and calcium levels
and synaptic vesicles exocytosis in rat brain synaptosomes.
Using MbCD we found that cholesterol removal from plasma
membrane induced spontaneous glutamate release and reduced
KCl-evoked release (Figs. 1 and 2). Such dual effect of MbCD is in
accordance with the study performed by Zamir and Charlton
(2006) showing that removal of cholesterol with MbCD increased
the frequency of MEPPS (mini excitatory postsynaptic potentials)
and also blocked the conductance of the action potential at the
glutamatergic neuromuscular junction of crayﬁsh. Moreover, Was-
ser et al. (2007) observed an increase in the frequency of spontane-
ous fusion events and a decrease in vesicular fusion, triggered by
stimulation in hippocampal neuronal cultures treated with MbCD.
The dual effects of MbCD on glutamate release in synaptosomes
described here suggest that cholesterol removal might interferewith the calcium-dependent (exocytotic) and/or calcium indepen-
dent (transporter mediated) components of release (Fig. 2). We
tested this paradigm by performing experiments in the presence
or absence of calcium and measured glutamate release in synpato-
somes pre-treated with MbCD (Fig. 3). We observed that the gluta-
mate release induced by MbCD was not calcium-dependent,
suggesting a putative effect on the glutamate transporter (Fig. 3A
and B). Indeed, Borisova et al. (2009), (2010) described an increase
in extracellular L-[14C] glutamate radioactivity in synaptosomes
treated with high concentrations of MbCD (15 mM). These authors
suggested that this effect might be due in part to a signiﬁcant
reduction in the rate of glutamate uptake by synaptosomes. How-
ever, when we investigated the calcium-dependence of the inhibi-
tory effect of MbCD on KCl-evoked glutamate release, we observed
that only the transporter mediated component remained after such
treatment (Fig. 3C and D) suggesting an effect exclusively in the
exocytotic component of release. In fact, this was conﬁrmed by
experiments where we measured synaptic vesicle exocytosis by
FM2-10 destaining (Fig. 6) and this increase in exocytosis by cho-
lesterol reduction has also been previously shown in neurons in
culture (Wasser et al., 2007; Linetti et al., 2010; Smith et al.,
2010). Therefore, our data shows that the same might be applied
for synaptosomes and that the discrepancy between our data and
the one from Borisova et al. (2009), (2010) may be due to differ-
ences in the MbCD concentration (ten times lower in our study)
and the technique to measure glutamate release. This inhibitory ef-
fect of cholesterol is essential for neurotransmission, since exceed-
ing spontaneous fusion of synaptic function may affect the long-
term synaptic function (Wasser et al., 2007). Moreover, unregu-
lated release of excitatory neurotransmitters may lead to damage
and neuronal death. High levels of glutamate are involved in sev-
eral degenerative diseases such as Alzheimer’s and Huntington’s
disease (Nishizawa, 2001; Hynd et al., 2004).
1158 G. Teixeira et al. / Neurochemistry International 61 (2012) 1151–1159Since voltage-gated calcium channels are concentrated in mem-
brane microdomains rich in cholesterol (Lang et al., 2001; Taverna
et al., 2004) the alterations in glutamatergic release after choles-
terol removal could be triggered by changes in the functioning
and location of these channels. However, our results indicate no
difference in intrasynaptosomal calcium concentration when cho-
lesterol was removed by MbCD (Fig. 4). Zamir and Charlton (2006),
using crayﬁsh neuromuscular junctions as model, also reported
that the increase in spontaneous exocytosis dependent MbCD de-
tected by them is independent of calcium. In addition, Wasser
et al. (2007) and Krysanova et al. (2007) showed that exocytotic re-
lease of aspartate and glutamate evoked by the calcium ionophores
A23187 and ionomycin was also lower after the removal of choles-
terol. Together these data indicate that the effects of MbCD cannot
be explained by changes in calcium inﬂux to the presynaptic
terminal.
Proteins related to vesicular fusion with the plasma mem-
brane, known as SNARES, are concentrated in membrane micro-
domains rich in cholesterol (Churchward et al., 2005; Gil et al.,
2005; Lang et al., 2001; Taverna et al., 2004). Thus, alterations
in spatial organization and/or physiology of these compounds
can cause changes in neurotransmitter release in cholesterol deﬁ-
ciency. Our data, as well as several works mentioned above, indi-
cate an increase in spontaneous neurotransmission during
cholesterol deﬁciency. However, the increase in spontaneous re-
lease of glutamate detected by ﬂuorescence (Fig. 1) was not
accompanied by a major decrease in the ﬂuorescence of FM2-10
in synaptosomes treated with MbCD, which may indicate an in-
crease in spontaneous exocytosis of synaptic vesicles (Fig. 5B
third column). At ﬁrst glance, this fact may suggest that the in-
creased spontaneous release by cholesterol removal might not
have vesicular origin. However, Wasser et al. (2007) also demon-
strated that in hippocampal neuronal cultures, the number of ves-
icles per synapse is increased during spontaneous release of
neurotransmitters when cells were treated with MbCD, which
suggests that there is an increase in fusion and recycling of syn-
aptic vesicles after removal of cholesterol. In this direction, Fredj
and Burrone (2009) demonstrated that the vesicular pool respon-
sible for the spontaneous release of neurotransmitters is different
from the one released after stimulation. Since the FM2-10, be-
cause of the intrinsic characteristics of this probe, stains only
the vesicular pools that are effectively recycling in the terminal,
the pool responsible for the spontaneous glutamate release, called
‘‘resting pool’’ by the these authors, would not be stained by the
probe. To test this hypothesis, synaptosomes were treated with
MbCD and then exposed to FM2-10. In this condition, the amount
of destaining evoked by MbCD was higher than that obtained
when KCl was used to label synaptic vesicles with the ﬂuorescent
dye, reinforcing the idea that a different pool of synaptic vesicles
is recruited during spontaneous or evoked synaptic vesicles re-
lease (compare Fig. 5A and Fig. 6A). Therefore, we suggest that
the resting pool could be one of the factors responsible for the in-
crease in spontaneous glutamate release not accompanied by
augmentation in spontaneous FM2-10 destaining (Fig. 5B, second
column).
In many synapses, spontaneous transmitter release is controlled
in part by various protein kinases and the activity of some of those
kinases might be sensitive to changes of membrane cholesterol
content (Burgos et al., 2004; Cabrera-Poch et al., 2004). Here we
provided evidences that spontaneous exocytosis activity depends
on PKA, PKC and CAMKII (Fig. 6E). Our results is in accordance with
previous data from Charlton’s group (Smith et al., 2010) showing
that in cerebellar neurons in culture, the rate of spontaneous neu-
rotransmitter release is increased following cholesterol depletion
by a mechanism requiring activation of presynaptic protein ki-
nases. In addition, previous data obtained in different cell culturemodels also corroborate the hypothesis that cholesterol removal
by MbCD might facilitate protein kinases activation. For example,
in MDCK cells MbCD treatment activates PKA without increasing
cAMP levels, possibly by disrupting inhibitory complexes localized
to lipid rafts (Burgos et al., 2004). Activation of PKCe and src in
MbCD-treated PC12 cells is also thought to be a consequence of
alterations to localized lipid domain interactions (Cabrera-Poch
et al., 2004). The precise nature of the phosphorylation event (s)
linking cholesterol depletion to increased spontaneous exocytosis
is not fully understood but the most plausible mechanistic expla-
nation is that lipid raft disruption allows active kinases access to
some component of the release apparatus and subsequent phos-
phorylation increases release probability.
5. Conclusion
In conclusion, this work shows the importance of membrane
cholesterol for efﬁcient neurotransmission. Acute removal of cho-
lesterol not only alters the structure of the plasma membrane,
but also acts on the functional state of synaptic vesicles therefore
interfering with the neurotransmitter release machinery. More-
over, our results give additional evidences that cholesterol appears
to be essential for the balance between spontaneous and evoked
release and this involves protein kinase activation.
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